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SUMMARY
Clinical signs, cellular infectivity and mortality rate of two closely related alpha-herpesvirus from a gaur (UPMV5/
05) and a bear (UPMVI9/05) were studied in mice experimentally infected via the nasal route. The grade of viral
infection was divided into low (l O'and 104 pfu/ml), medium (105and 106 pfu/ml) and high (107 pfu/ml). Clinically, all
animals with the exception of controls, showed respiratory and neurological signs starting from 36 hpi. Although
there were a number of differences in the onset time of clinical signs, these were not significant and the types of
clinical signs shown were common. Nevertheless, there was a significant difference in the mortality rate, in which
isolate UPMVI9/05 from a bear was more pathogenic (83%) than the gaurisolate, UPMV5/05 (16.7%). These results
strongly suggest that the consequences of host adaptation of herpesviruses may have been derived from
interspecies transmission and underscore the need for extreme caution when managing wild or captive animals in close
proximity to bovines.
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INTRODUCTION
The family herpesviridae consists of viruses that
have been isolated from a wide range of animal species,
human beings-catfish, and invertebrates such as oysters
(Ardans, 1992), and can be divided into three major
subfamilies: alpha-, beta-, and gamma-herpesvirinae.
Within this group of viruses, there is wide variation in
biological properties including cytopathology,
pathogenicity, a propensity to form latent infections, and
oncogenic potential.
In most natural hosts, animal herpesvirus produces
a highly fatal infection that can affect all types of animals
either pets, livestock or wildlife. Some important diseases
caused by this virus include Infectious Bovine
Rhinotracheitis (IBR) and Malignant Catarrhal Fever
(MCF) in bovine, Equine Laryngotracheitis, Equine
Abortion and Equine Coital Exanthema (ECE) in equine,
Canine Herpesvirus in canines and Feline Rhinotracheitis
in felines. However, despite the infectivity of this virus
in various species, its infection in wildlife has rarely
been detected and reported.
This study was initiated to investigate two different
hespesvirus isolates (UPMV5/05 and UPMVI9/05) from
two different captive wildlife species (gaur and bear
respectively) from two different areas in Malaysia.
Preliminary genome investigation using BamHI digested
restriction enzyme (RE) pattern revealed close similarity
within their genomes. In addition, the RE pattern of both
isolates also resembled that of a bovine herpesvirus
(BHV) giving an indication of the same origin. To gather
further information on their pathogenicity and clinical




Two purified cell culture herpesvirus isolates were
obtained from the Virology Laboratory of Faculty of
Veterinary Medicine, Universiti Putra Malaysia. They were
isolated from cases of captive wildlife animals from
different areas in Malaysia. Isolate UPMV5/05 was
obtained from a blood sample of a gaur whilst isolate
UPMVI9/05 was obtained from an oral swab of a growth
on a mandibular region of a bear.
Virus stock preparation
Each viral isolate was propagated in Vero cell line
and prepared in stock. The stock titre was determined by
plaque forming assay (pfu). Different concentrations of
titre were produced for each herpesvirus isolate: 101,106,
lOS,104and IO'pfu/ml.
Negative Contrast Electron Microscopy (NCEM)
The purified virus was examined under an elec-tron
microscope. One drop of the purified virus was placed
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on wax paper, and carbon-fonnvar coated copper grid
was layered with the carbon side down on the drop for
five minutes. The grid was picked up with forceps and
excess fluid was removed by filter paper. This step was
followed by placing the grid with its carbon side down
on a drop of2% (w/v) methylamine tungstate for another
five minutes. The excess fluid was removed as described
above and the grid was dried overnight before being
examined under a Hitachi 7100 Transmission Electron
Microscope (TEM).
Intranasal inoculation of virus into mice
Balb/c inbred mice (5-8 weeks old) were obtained
from the Institute for Medical Research, Kuala Lumpur,
Malaysia. Each isolate was intranasally inoculated into 5
groups of mice at 5 different concentrations, of 103,10\
105, 106 and 107 pfulml. Six uninfected mice served as
controls.
Monitoring of clinical signs
In order to ensure proper clinical signs monitoring
throughout the experiment, several methods were
employed. These included visualisation with naked eyes,
video recording and photography. All finding were
recorded and tabulated. Monitoring commenced after
the animals were infected. Protocols in management of
the mice were in accordance to the standard laboratory
animal husbandry which conforms to standard ethical
practices. In this study, the onset of clinical signs was
very subtle because of individual variation in immune
status. It was therefore more convenient to observe the
signs in groups oflow (103 II04pfulml), medium (105/106
pfulml) and high (107 pfulml) viral doses.
Mortality rate
The mortality rate, also known as fatality rate, is
summed as the ratio of the total number of deaths to the
total number of the population, Mortality rate in this trial
is expressed in percentage as shown below:
Mortality rate = No. of dead mice (each dose) X 100%
No. of mice inoculated (each dose)
Statistical analysis
All data were analysed using SPSS version 16.0.
Student t-test was used and the significant level was set
atp<0.05.
RESULTS
Viral propagation in cell culture
The cytopathic effect (CPE) was first observed at 24
hours post-infection (hpi) and continued progressively
towards completion at 72 hpi (Figure lA). CPE types of
different characteristics were produced by each isolate.
Vero cells infected with UPMV19/05 showed a large
syncytium (Figure lB)whilst infection with UPMV5105
produced plaque containing vacuoles, rounded
polykaryocytes and multiple peripheral cytoplasmic
extensions (Figure 1C).
Figure 1: Normal uninfected and infected Vero cells at 72 hpi. (A) The spindle shape of the normal uinfected Vero
cells; (B) UPMV19/0S infected Vero cells showed extensive fusion of cells and syncytium formation; (C)
Isolate VS/OSIUPM on Vero cells at 72 hpi with arrows showing CPE characterised by a large plaque
containing vacuoles and rounded polykaryocytes with multiple peripheral cytoplasmic extensions
(magnification 20x).
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Figure 2: Electron micrograph of isolate UPMVS/OS. The envelope (arrow) of the herpesvirus was intact and
covering the capsid (arrowhead) (magnification 10000x).
Figure 3: General observation of clinical signs after herpesvirus infection in mice at different time frames. Mice
became depressed (A) and huddling together (B) after S hpi, At 10 hpi, mice started to rub their mouth
and nose intensively (C). On day 2 (36 hpi), mice showed signs ofruflled hair (D). Bleeding nose (E) and
ears (F) were observed at 60 hpi (day 3). Mice showed hunched back position (G) at 84 hpi and lastly they
showed tilted head (H) prior to death.
Negative Contrast Electron Microscopy (NCEM) General observation of clinical signs
Each concentrated viral stock was prepared for
NCEM. Figure 2, based on UPMVSIOS, represents the
characteristic icosahedral feature of herpesvirus. Under
NCEM, the herpesvirus was easily identified and
confirmed by the presence of the capsid of the virion
which appeared as a hexagonal ring, and enveloped by
an electron-translucent shell ranging from 100-102 nm in
diameter.
The first clinical signs after infection with herpesvirus
were observed at S hpi (Day 1) when mice became
depressed (Figure 3A) and huddled together (Figure 3B)
at one comer. Depression was presented with decreasing
functional activity, decreased interest in surroundings
or decreased response to external stimuli while huddling
means crowding closely. At the subsequent S hpi, the
animals were observed to rub their mouth and nose (Figure
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3C) intensively due to itchiness. At 36 hpi (day 2), they
showed signs of ruffled hair (Figure 3D), trembling and
shivering. Ruffled hair is denoted as disturbed
smoothness or tranquillity of hair. Trembling refers to
visible muscle tremor and shivering as involuntary
shaking of the body.
Heavy dyspnoea with tachypnoea was observed at
60 hpi (Day 3). Dyspnoea is denoted as laboured or difficult
breathing whereas tachypnoea is very rapid respiration,
the rate being fast and the depth shallow. Frequent attacks
were characterised by extensive scratching of the face,
nose, maxillary region (Figure 3E) and ears (Figure 3F).
These were observed to cause severe hemorrhagic dermal
erosions and ulcerations at 60 hpi (Day 3).
At 72 hpi (Day 3), signs of uncoordinated gait and
circling movement were observed. Uncoordination is
denoted as a lack of normal adjustment of muscular action
whereas circling is persistent walking in circles. Lastly, at
84 hpi (Day 4), the animals showed a hunched position
(Figure 3G) as indicated by their abdomen being drawn
up with head down with their four feet underneath and
prior to death, they showed a tilted head (Figure 3H)
which includes rotation and deviation.
Onset of clinical signs
Table 1 summarises the onset of clinical signs for
isolates UPMV5/05 and UPMVI9/05. Briefly, the medium
and high viral doses triggered earlier clinical signs
compared to lower grade infection; however, no
significant difference was observed in infections between
the two isolates.
Mortality rate induced by isolate UPMV5105 and
UPMV19105 in murine models
Table 2 presents the mortality rate caused by isolates
UPMV5/05 and UPMV19/05 during the first week of post-
viral inoculation. The mortality rate was 100% from a
concentration of 105 pfu/ml up to107 pfu/ml for both
isolates. A significant difference was observed when
inoculated with a lower viral concentration (103pfulml)
which produced 16.7% and 83.3% mortality rates,
respectively at Day 7 post infection (pi) for UPMV5/05
and UPMV 19/05. At medium and high dose infection (1OS
pfulml to 107 pfu/ml), death of mice started from Day 2 pi
with all mice being dead by Day 5 pi. For the lower
concentration (1()4 pfu/ml and IOJpfu/ml), murine mortality
was from Day 4 onwards till Day 7 pi. All control mice
were alive throughout the entire experimentation period.
DISCUSSION
Herpesviridae sub-families can be distinguished by
cytopathology and also host range, duration of
replicative cycle, and latent infection characteristics
(Ardans, 1990). The Vero cell line supported the
replication of both UPMV5/05 and UPMV19/05 isolates
and subsequently showed first signs of cytopathic effect
(CPE) at 24 hpi which were completed by 72 hpi. The
rapid CPE formation strongly suggests alpha-
herpesvirus, which has a relatively short replication cycle
«24 hpi). Although, the UPMV5/05 isolate from the gaur
was suspected initially of malignant cattarhal disease
(gamma-herpesvirus), the extensive spread of CPE within
a short period of time contradicted the slow progressive
cytopathic pattern of either beta or gamma-herpesvirus
(Browning and Studdert, 1988). While alpha-
herpesviruses are notably cytopathic, most lymphotropic
herpesviruses (gamma-herpesvirus) do not cause
significant degree of cellular injury. The Vero cell line
allows higher replication titre of the herpesvirus,
specifically alpha-herpesvirus, in comparison to other
used cell lines at a similar passage (Warda, 2007). Both
herpesvirus isolates have the tendency to induce fusion
Table 1: Onset of clinical signs in mice inoculated with different doses of herpesvirus isolates UPMVS/OS and
UPMVI910S
Clinical Signs (h.p.i.) V5 (pfu/ml) V19 (pfu/ml)
103/104(low) lOs/l06(medium)107(high) 103/104(low) lOs/l06(mcdium)107(high)
Depression 10 5 5 12 5 5
Huddling 10 5 5 12 5 5
Rubbing mouth! nose 5 5 5 10 5 5
Ruffled hair 41 36 36 41 36 36
Trembling! shivering 41 36 36 41 36 36
Dyspnea! tachypnea 65 60 60 65 60 60
Bleeding nose/ ears 65 60 60 65 60 60
Uncoordinated gait 77 72 72 77 72 72
Circling movement 77 72 72 77 72 72
Hunched position 89 84 84 89 84 84
Tilted head 89 84 84 89 84 84
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Table 2: Mortality rate of Balb/c mice infected with different doses of herpesvirus isolates UPMV5/05 and UPMV19/05
Days post
inoculation V5 (pfu/ml) V19 (pfu/m!)
C 103 104 105 106 107 C 103 104 105 106 107
Day 1
Day 2 2 1 4
Day 3 4 3 1 7 5 2
Day 4 2 5 3 3 1 1 3 2
Day 5 3 2 1 2 1
Day 6 1 1
Day 7 1 1 1 1
Total Dead 0 1 6 8 8 8 0 5 5 8 8 8
Total Alive 3 5 0 0 0 0 3 1 1 0 0 0
Total Animals Used 3 6 6 8 8 8 3 6 6 8 8 8
Mortality Rate (%) 0.0 16.7" 100.0 100.0 100.0 100.0 0.0 83.3b 83.3 100.0 100.0 100.0
Different alphabets in the same row indicate significant difference (p<O.05).
C = Control
- = None
of membranes of adjacent cells, merging to a mass of
cytoplasm containing more than one nucleus, known as
a syncytium. However, fused cells are short lived and
subsequently lyse; apart from direct effects of the virus,
they cannot tolerate more than one non-synchronised
nucleus per cell.
As both virus isolates showed similar replication
time frames in the same cell line, the possibility that both
viruses are closely related is high. Further characterisation
was performed to investigate the clinical signs in the
infected murine models. The observed clinical symptoms
included non-specific and specific signs. Non-specific
signs were signs associated with the animal undergoing
the disease process such as depression, huddling, ruffled
hair, closed eyelids, loss of appetite (anoretic) and
inactive (apathetic) (Takafumi, 1996), whereas the specific
signs were herpesvirus related clinical signs after
introduction to the body system. Two main body systems
involved in herpesvirus pathogenicity are the respiratory
system and nervous system (Ritchey et al., 2005). Signs
of the respiratory system of the disease process are
rubbing mouth and nose intensively and also respiratory
distress (dyspnoea and tachypnoea) whilst neurological
signs include trembling and shivering, uncoordinated
gait, circling movement, muscle tremor, tilted head, seizure
and paralysis (Rizvi et al., 1997; Ardans et al., 1992). Both
UPMV5/05 and UPMVI9/05 presented similar clinical
manifestation with some slight differences in the time of
onset which were not significant.
Viral pathogenesis is a complex, variable, and
relatively rare state; however, like the course of a virus
infection, pathogenesis is determined by a balance of
host and virus factors. All mice infected with UPMV5/05
and UPMV19/05 died when inoculated with viral doses
of lOS pfulml to 107 pfulml. The first observation of death
began on Day 2 pi and all mice died by Day 5 pi. However,
death started a day later in low grade infection (103 pfu!
ml-Itr'pfu/ml) and resulted in a mortality rate of 16.7%
and 83.3% at Day 7 pi for UPMV5/05 and UPMVI9/05
respectively. There was a significant difference (p<0.05)
in the mortality rate of these two viral isolates at lower
grade infection. The variation in pathogenicity implies
the consequence of an adaptation to a new host, although
both isolates appeared similar genetically and in the
manner of triggering clinical symptoms.
The ability of BHV to infect different animal species
may have important implications for control or eradication
efforts. Incidence oflER (an alpha-herpesvirus) in buffalo
in Malaysia is an example of a virus infecting related
species in close contact (Ibrahim et al., 1983). Other alpha-
herpesvirus, such as equine herpesvirus 9 (EHV9) have
managed to cross species and infect a polar bear and
the case resembled a fatal herpesvirus encephalitis
(Schrenzel et al. 2008; Donovan et al., 2009). Likewise,
the Bam HI DNA restriction pattern of the bear isolate
was almost similar to the gaur isolate, UPM V5/05
(unpublished data). Both resembled a BHV origin. A
characteristic herpesvirus, exclusive to the bear, has yet
to be identified. It may have not been caused by a
completely new or unknown virus but by viruses that
were well known in the geographical areas. The variation
in the pathogenicity of the seemingly similar isolates of
UPM V5/05 and UPMVI9/05, apparently from known
BHVorigin might have crossed the species barrierand
eventually appear to have changed their behaviour. In
other words, host adaptation may have triggered genetic
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changes which altered their behaviour with time, with
significant effects on their pathogenesis.
CONCLUSION
In conclusion, isolates UPMV5/05 and UPMV19/05
showed similar clinical presentation and minimal
differences in terms of onset of clinical signs and
significant variation in mortality at lower grade infection
in the murine model. Although, the initial thought was
that both isolates were the same virus strain due to the
close similarity in genetic fingerprinting to BHV, this study
found otherwise. Thus, it is reasonable to expect that
animals raised in close contact with cattle in areas where
BHV is endemic are vulnerable to interspecies viral
transmission and therefore should be considered
potential reservoirs of the virus. Due to these concerns,
a geographically targeted survey of potentially infected
animals for BHV is highly recommended especially in
zoo, zoological gardens and animal sanctuaries.
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